{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:56:30Z","timestamp":1790754990267,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:00:00Z","timestamp":1609372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MO 384\/6-1"],"award-info":[{"award-number":["MO 384\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA2367\/6-1"],"award-info":[{"award-number":["MA2367\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The neoplastic Hodgkin\/Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL) depend on chronic activation of the Janus kinase (JAK)\/signal transducer and activator of transcription (STAT) signalling pathways to maintain survival and proliferation. Accumulating reports highlight the importance of the inactivation or reduced expression of negative JAK\/STAT regulators such as the protein-tyrosine phosphatase 1B (PTP1B\/PTPN1) in this process. Various PTPN1 mRNA variants as well as truncated PTP1B proteins were identified in cHL cell lines and primary cHL tumour samples. These PTPN1 mRNA variants lack either one or several exon sequences and therefore render these PTP1B variants catalytically inactive. Here, we show that one of these mutants, PTP1B\u22062\u20134, is not only a catalytically inactive variant, but also augmented the IL-4-induced JAK\/STAT activity similar to the recently reported PTP1B\u22066 splice variant. Moreover, while PTP1B\u22066 diminished the activity and protein levels of PTP1BWT, PTP1BWT remained unaffected by PTP1B\u22062\u20134, arguing for different molecular mechanisms of JAK\/STAT modulation by PTP1B\u22066 and PTP1B\u22062\u20134. Collectively, these data indicate that PTPN1 variants missing one or more exon sequences originated either from alternative splicing or from gene mutation, create PTP1B gain-of-function variants with oncogenic potential by augmenting JAK\/STAT signalling in cHL.<\/jats:p>","DOI":"10.1093\/carcin\/bgaa144","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T20:15:51Z","timestamp":1609359351000},"page":"517-527","source":"Crossref","is-referenced-by-count":15,"title":["The PTP1B mutant PTP1B\u22062\u20134 is a positive regulator of the JAK\/STAT signalling pathway in Hodgkin lymphoma"],"prefix":"10.1093","volume":"42","author":[{"given":"Malena","family":"Zahn","sequence":"first","affiliation":[{"name":"Institute of Pathology, Ulm University, Albert-Einstein-Allee, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Kaluszniak","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Ulm University, Albert-Einstein-Allee, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Ulm University, Albert-Einstein-Allee, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1309-1429","authenticated-orcid":false,"given":"Ralf","family":"Marienfeld","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Ulm University, Albert-Einstein-Allee, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,31]]},"reference":[{"key":"2021043015502766100_CIT0001","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/ijc.21716","article-title":"Molecular biology of Hodgkin\u2019s and Reed\/Sternberg cells in Hodgkin\u2019s lymphoma","volume":"118","author":"Br\u00e4uninger","year":"2006","journal-title":"Int. J. Cancer"},{"key":"2021043015502766100_CIT0002","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ajh.24272","article-title":"Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Ansell","year":"2016","journal-title":"Am. J. Hematol."},{"key":"2021043015502766100_CIT0003","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"K\u00fcppers","year":"2012","journal-title":"J. Clin. Invest."},{"key":"2021043015502766100_CIT0004","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.4459","article-title":"The Epstein-Barr virus and the pathogenesis of lymphoma","volume":"235","author":"Vockerodt","year":"2015","journal-title":"J. Pathol."},{"key":"2021043015502766100_CIT0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"2021043015502766100_CIT0006","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J. Immunol."},{"key":"2021043015502766100_CIT0007","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bjc.2015.233","article-title":"The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours","volume":"113","author":"Thomas","year":"2015","journal-title":"Br. J. Cancer"},{"key":"2021043015502766100_CIT0008","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tibs.2010.03.004","article-title":"PTP1B: a double agent in metabolism and oncogenesis","volume":"35","author":"Yip","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"2021043015502766100_CIT0009","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"2021043015502766100_CIT0010","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.bbrc.2009.07.105","article-title":"Implication of protein tyrosine phosphatase 1B in MCF-7 cell proliferation and resistance to 4-OH tamoxifen","volume":"387","author":"Blanquart","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"2021043015502766100_CIT0011","doi-asserted-by":"crossref","first-page":"21922","DOI":"10.18632\/oncotarget.7829","article-title":"Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome","volume":"7","author":"Hoekstra","year":"2016","journal-title":"Oncotarget"},{"key":"2021043015502766100_CIT0012","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat. Genet."},{"key":"2021043015502766100_CIT0013","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/blood-2016-06-720516","article-title":"A novel PTPN1 splice variant upregulates JAK\/STAT activity in classical Hodgkin lymphoma cells","volume":"129","author":"Zahn","year":"2017","journal-title":"Blood"},{"key":"2021043015502766100_CIT0014","first-page":"1","author":"Union for International Cancer Control","year":"2014"},{"key":"2021043015502766100_CIT0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000112062","article-title":"U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma","volume":"119","author":"Mader","year":"2007","journal-title":"Cytogenet. Genome Res."},{"key":"2021043015502766100_CIT0016","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1074\/jbc.M110.155895","article-title":"The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation","volume":"286","author":"Palkowitsch","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021043015502766100_CIT0017","first-page":"71","article-title":"An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis","volume":"3","author":"Rao","year":"2013","journal-title":"Biostat. Bioinforma. Biomath."},{"key":"2021043015502766100_CIT0018","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2121-11-99","article-title":"3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including \u201ct-stumps\u201d","volume":"11","author":"Knecht","year":"2010","journal-title":"BMC Cell Biol."},{"issue":"21","key":"2021043015502766100_CIT0019","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood.V122.21.242.242","article-title":"Protein tyrosine phosphatase type-1 (PTPN1) is frequently mutated in primary mediastinal B cell lymphoma and Hodgkin lymphoma No Title","volume":"122","author":"Gunawardana","year":"2013","journal-title":"Blood"},{"key":"2021043015502766100_CIT0020","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"2021043015502766100_CIT0021","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"2021043015502766100_CIT0022","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood.V97.1.250","article-title":"Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"97","author":"Skinnider","year":"2001","journal-title":"Blood"},{"key":"2021043015502766100_CIT0023","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/ijc.21539","article-title":"Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells","volume":"118","author":"Baus","year":"2006","journal-title":"Int. J. Cancer"},{"key":"2021043015502766100_CIT0024","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/blood.V98.3.762","article-title":"STAT3 is constitutively activated in Hodgkin cell lines","volume":"98","author":"Kube","year":"2001","journal-title":"Blood"},{"key":"2021043015502766100_CIT0025","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"2021043015502766100_CIT0026","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/leu.2017.136","article-title":"JAK\/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias","volume":"31","author":"Delgado-Martin","year":"2017","journal-title":"Leukemia"},{"key":"2021043015502766100_CIT0027","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002371-200409000-00003","article-title":"Combination of the human anti-CD30 antibody 5F11 with cytostatic drugs enhances its antitumor activity against Hodgkin and anaplastic large cell lymphoma cell lines","volume":"27","author":"Heuck","year":"2004","journal-title":"J. Immunother."},{"key":"2021043015502766100_CIT0028","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2174\/1389450115666141120104146","article-title":"The role of STAT3 signaling in mediating tumor resistance to cancer therapy","volume":"15","author":"Tan","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"2021043015502766100_CIT0029","first-page":"1081","article-title":"Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway","volume":"39","author":"Chen","year":"2018","journal-title":"Oncol Rep."},{"key":"2021043015502766100_CIT0030","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3892\/mmr.2014.2949","article-title":"Upregulation of Stat1-HDAC4 confers resistance to etoposide through enhanced multidrug resistance 1 expression in human A549 lung cancer cells","volume":"11","author":"Kaewpiboon","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"2021043015502766100_CIT0031","first-page":"12","article-title":"The good and the bad faces of STAT1 in solid tumours","volume-title":"Cytokine","author":"Meissl","year":"2017"},{"key":"2021043015502766100_CIT0032","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2015.12.025","article-title":"TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies","volume":"82","author":"Pike","year":"2016","journal-title":"Cytokine"},{"key":"2021043015502766100_CIT0033","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","article-title":"Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6","volume":"110","author":"Mottok","year":"2007","journal-title":"Blood"},{"key":"2021043015502766100_CIT0034","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/cas.13194","article-title":"Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy","volume":"108","author":"Chikuma","year":"2017","journal-title":"Cancer Sci."},{"key":"2021043015502766100_CIT0035","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3324\/haematol.2011.041921","article-title":"Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin\u2019s lymphoma and T-cell non-Hodgkin\u2019s lymphoma","volume":"96","author":"Kleppe","year":"2011","journal-title":"Haematologica"},{"key":"2021043015502766100_CIT0036","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1021\/bi990240v","article-title":"Regulation of PTP1B via glutathionylation of the active site cysteine 215","volume":"38","author":"Barrett","year":"1999","journal-title":"Biochemistry"},{"issue":"9","key":"2021043015502766100_CIT0037","first-page":"15366","article-title":"Reversible inactivation of protein tyrosine phosphatase IB by hydrogen peroxide generated in A431 cells stimulated with epidermal growth factor","volume":"11","author":"Lee","year":"1997","journal-title":"FASEB J"},{"key":"2021043015502766100_CIT0038","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/mend.15.10.0711","article-title":"Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor","volume":"15","author":"Ravichandran","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"2021043015502766100_CIT0039","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32347","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"2021043015502766100_CIT0040","first-page":"613","article-title":"The two faces of PTP1B in cancer","volume-title":"Biochim. Biophys. Acta - Proteins Proteomics","author":"Lessard","year":"2010"},{"key":"2021043015502766100_CIT0041","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1073\/pnas.0304242101","article-title":"The role of protein tyrosine phosphatase 1B in Ras signaling","volume":"101","author":"Dub\u00e9","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2021043015502766100_CIT0042","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1742-4658.2012.08563.x","article-title":"PTP1B and TCPTP\u2013nonredundant phosphatases in insulin signaling and glucose homeostasis","volume":"280","author":"Tiganis","year":"2013","journal-title":"FEBS J."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgaa144\/36893560\/bgaa144.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/42\/4\/517\/37697964\/bgaa144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/42\/4\/517\/37697964\/bgaa144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T15:55:57Z","timestamp":1619798157000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/42\/4\/517\/6056480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,31]]},"published-print":{"date-parts":[[2021,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgaa144","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,12,31]]}}}